Legionella pneumophila is a facultative intracellular Gram-negative rod-shaped bacterium that has become an important cause of both community-acquired and nosocomial pneumonia. Numerous studies concerning the unravelling of the virulence mechanism of this important pathogen have been initiated. As evidence is now accumulating for the involvement of protein secretion systems in bacterial virulence in general, the type I signal peptidase (LepB) of L. pneumophila was of particular interest. This endopeptidase plays an essential role in the processing of preproteins carrying a typical amino-terminal signal peptide, upon translocation across the cytoplasmic membrane. This paper reports the cloning and the transcriptional analysis of the L. pneumophila lepB gene encoding the type I signal peptidase (SPase). Reverse transcription PCR experiments showed clear lepB expression when L. pneumophila was grown both in culture medium, and also intracellularly in Acanthamoeba castellanii, a natural eukaryotic host of L. pneumophila. In addition, LepB was shown to be encoded by a polycistronic mRNA transcript together with two other proteins, i.e. a LepA homologue and a ribonuclease III homologue. SPase activity of the LepB protein was demonstrated by in vivo complementation analysis in a temperature-sensitive Escherichia coli lepB mutant. Protein sequence and predicted membrane topology were compared to those of leader peptidases of other Gram-negative human pathogens. Most strikingly, a strictly conserved methionine residue in the substrate binding pocket was replaced by a leucine residue, which might influence substrate recognition. Finally it was shown by in vivo experiments that L. pneumophila LepB is a target for (5S,6S)-6-[(R)-acetoxyethyl]-penem-3-carboxylate, a specific inhibitor of type I SPases.
INTRODUCTION
Legionella pneumophila, the causative agent of Legionnaires' disease in man, is a Gram-negative facultative intracellular parasite of monocytes and alveolar macrophages. In the environment, L. pneumophila inhabits fresh water, where it can reside and proliferate within various free-living protozoa, or is present in a biofilm-associated state. Human infection can occur following inhalation of small aerosolized droplets containing Legionella cells. Since the initial isolation of L. pneumophila in 1976, significant progress has been made in identifying virulence determinants for entry and intracellular multiplication in eukaryotic hosts. As in other Gram-negative pathogens, these virulence factors are usually proteins and are generally either secreted into the extracellular environment or attached to the cell surface (Finlay & Falkow, 1997) . Although the secreted proteins are numerous and diverse, only a few pathways exist by which these proteins are transported from the bacterial cytoplasm to the extracellular environment (reviewed by Lee & Schneewind, 2001 ). For L. pneumophila, the presence of type II and type IV secretion systems has been described. The first type IV apparatus, encoded by the icm/dot genes , was shown to be required for export of virulence factors that play a role in evasion of the endocytic maturation pathway upon infection and in the recruitment of secretory vesicles to L. pneumophila containing phagosomes. A second type IV secretion system, with strong homology to the Agrobacterium tumefaciens Vir system for T-DNA transfer and the system for secretion of Bordetella pertussis toxin (reviewed by Christie, 2001), was described (Segal et al., 1999) . This system, encoded by lvh (Legionella vir homologues) genes, was, however, found to be dispensable for intracellular growth in macrophages and Acanthamoeba castellanii. A set of genes (called lsp) encodes products with homology to proteins of the type II secretion pathway in other Gram-negative bacteria (Hales & Shuman, 1999) . Another study on type II secretion demonstrated the presence of a pilBCD locus, later shown to be involved in formation of type IV pili and the assemblage of a type II protein secretion system (Liles et al., 1999; Rossier et al., 2004) . Mutagenesis of lsp genes and the prepilin peptidase gene pilD revealed that type II secretion promotes the ability to infect both protozoan and macrophage hosts and to grow in the mammalian lung (Hales & Shuman, 1999; Liles et al., 1999; Rossier et al., 2004) . In L. pneumophila, different proteins were shown to depend on the type II secretion machinery for transport across the outer membrane. These include a zinc metalloprotease, lipases, phospholipase A, acid phosphatase, RNase and an esterase (Liles et al., 1999; Aragon et al., 2000 Aragon et al., , 2001 Aragon et al., , 2002 . In general, proteins secreted by this type II pathway follow an initial Sec-dependent step for export across the inner membrane. The crossing of the outer membrane involves the formation of a pore, by a set of additional inner-and outer-membrane proteins (Sandkvist, 2001) . The exported proteins are synthesized as preproteins, carrying a typical amino-terminal signal sequence, involved in targeting the precursors to and passage through the inner membrane. The signal peptide consists of three distinct domains, of which the carboxy-terminal C-domain allows sequence-specific cleavage by the type I signal peptidase (SPase), a membrane-bound endopeptidase. Statistical analysis of the amino acid residues constituting the SPase recognition site has led to the so-called (2321) rule, which states that the residues at the 23 and 21 positions, relative to the mature part, must be small and neutral residues with a strong preference for alanine (von Heijne, 1983 ). Therefore, the consensus SPase recognition site is often designated Ala-X-Ala. The type I SPase plays a key role in the secretion process by removing the signal peptide and, in this way, releasing the mature protein. Type I SPases have been identified in eubacteria, archaea, the thylakoid membrane of chloroplasts, the inner membrane of mitochondria and the endoplasmic reticulum of yeast and higher eukaryotes (Paetzel et al., 2002) . So far, the leader peptidase (LepB) of the Gram-negative Escherichia coli is the best characterized SPase (for a review see Paetzel et al., 2000) . Although many Gram-negative bacteria have only one SPase for preprotein processing, multiple type I SPases can be present.
Type I SPases belong to a novel group of serine proteases and have been classified into the evolutionary clan of serine proteases SF, which utilize a Ser-Lys or Ser-His catalytic dyad rather than the more common Ser-His-Asp triad mechanism (Black, 1993; Paetzel et al., 1998) . Type I SPases can be irreversibily inhibited by certain penem compounds which are responsible for the acylation of the serine residue in the active site (Black & Bruton, 1998; Paetzel et al., 1998) . SPase activity was found to be essential for cell viability, defining type I SPases as potential targets for the development of novel antibacterial agents.
We report here on the cloning and transcriptional analysis of the L. pneumophila lepB gene encoding the SPase I. In addition, functional activity of the encoded protein was demonstrated by complementation analysis in an E. coli SPase mutant. Finally, the effect of a penem derivative on growth of L. pneumophila and an E. coli temperaturesensitive SPase mutant expressing L. pneumophila lepB was evaluated.
METHODS
Strains, media and growth conditions. L. pneumophila (ATCC 33152) was cultured on buffered charcoal yeast extract (BCYE) agar plates or in buffered yeast extract broth (BYE) (Edelstein, 1981) supplemented with 2-oxoglutarate, L-cysteine and ferric pyrophosphate, at 37 uC and 5 % CO 2 . E. coli strains were grown in LuriaBertani medium (Miller, 1972) , if necessary supplemented with ampicillin (50 mg ml
21
) or chloramphenicol (25 mg ml
). For functional complementation analysis, the E. coli strain IT89, containing a temperature-sensitive mutation in lepB, was used (Inada et al., 1989) ; this strain was grown at 27 uC. Acanthamoeba castellanii (ATCC 30234) was cultured in Acanthamoeba medium (Moffat & Tompkins, 1992) at room temperature.
DNA manipulations. All DNA manipulations, including purification, restriction digestion, ligation, agarose gel electrophoresis, PCR amplification and transformation of E. coli cells, were performed using standard techniques (Sambrook et al., 1989) . Restriction endonucleases and other DNA-modifying enzymes were purchased from Roche Diagnostics and Invitrogen-Life Technologies. Oligonucleotides (Table 1) Plasmid constructions. The L. pneumophila lepB gene was isolated by PCR using the primers LspF and LspR, from chromosomal DNA (100 ng) as template. To enable final detection of the encoded protein at a later stage, a sequence encoding the c-Myc tag was introduced into the LspR primer. To facilitate cloning, LspF and LspR primers were designed with NdeI and BamHI restriction sites, respectively. PCR was performed on a Mini Cycler PTC-150 (MJ Research) using SuperTaq polymerase (HT Biotechnology) under the following conditions: an initial denaturation step of 3 min at 95 uC, 30 cycles of (30 s at 95 uC, 45 s at 50 uC, 1 min at 72 uC), and a final extension for 5 min at 72 uC. The resulting 0?8 kb PCR fragment was cloned into pGEM-T Easy (Promega) and the DNA sequence was determined. Subsequently, the lepB gene was cloned as an NdeI-BamHI restriction fragment behind the tac promoter and a suitable ribosome-binding site (RBS) in pEX50 (Geukens et al., 2001) , resulting in pEXLepLpn. Additionally, the same restriction fragment containing the lepB gene was inserted behind the lac promoter in pBCN, which is a pBC-KS + (Stratagene) derivative with a NdeI site introduced at the start codon of the lacZa gene, resulting in pBCNLepLpn.
Southern blot hybridization. Genomic DNA from L. pneumophila was digested with specific restriction enzymes (EcoRV, EcoRI and HindIII) and separated by agarose gel electrophoresis. DNA fragments were subsequently transferred to Hybond-N membranes (Amersham Biosciences) using a vacuum blot device (VacuGene, Amersham Biosciences). A lepB-specific DNA probe was generated by labelling the PCR fragment obtained with primers LspF and LspR with digoxigenin (DIG) according to the instructions of the manufacturer (Roche Diagnostics). The UV cross-linked DNA fragments were hybridized with the lepB-specific probe as described previously (Engler-Blum et al., 1993) . Hybridization signals were detected using 0?25 mM CDP-Star (Roche Diagnostics) according to the method of Hoeltke et al. (1995) .
RNA isolation and RT-PCR experiments. Total RNA was isolated from L. pneumophila cultures grown to exponential and stationary phase using the RNeasy mini kit (Qiagen). For this purpose, the cells from 3 ml of culture were collected by centrifugation, the RNAs were fixed using the RNA Protect kit (Qiagen) and the samples frozen at 220 uC until immediately prior to use. To investigate whether the L. pneumophila lepB gene was also expressed when the cells were grown intracellularly, total RNA was isolated from L. pneumophila grown within A. castellanii. For these experiments, A. castellanii, adherently grown in a 24-well plate, was infected with L. pneumophila cells at an m.o.i. of 1. Infection was allowed to proceed for 2 h at 37 uC and then gentamicin (100 mg ml 21 ) was added for 1 h to kill the bacteria present in the extracellular environment; this represents the initial time point (0 h). At 24 h and 48 h postinfection, culture supernatants from 12 wells were collected and the bacteria were released from the amoebae by hypotonic lysis with icecold distilled water. After mixing the released bacteria with those present in the cell culture supernatant, bacteria were collected and RNA was isolated as described above. As L. pneumophila does not replicate in cell culture medium, the bacteria present in the samples result from intracellular growth and subsequent host cell lysis. After isolation, a control for the quality of the RNA samples was carried out by 1?3 % agarose-formaldehyde gel electrophoresis followed by ethidium bromide staining. RT-PCR experiments were carried out using the various primers given in Table 1 (see also Fig. 3 ) by means of the Access RT-PCR kit (Promega). Initial synthesis of the cDNA strand and subsequent amplification were carried out starting from 0?5 mg total RNA using the following cycling conditions: 45 min at 48 uC, 3 min at 95 uC, 40 cycles of (30 s at 95 uC, 45 s at 50 uC, 2 min at 72 uC), 5 min at 72 uC. The same reactions were also performed on RNA treated with RNase to check for the possible presence of traces of DNA in the samples.
Protein analysis, SDS-PAGE and immunodetection. Expression of the LepB protein was monitored by Western blotting (12?5 % SDS-PAGE) and immunodetection with antibodies directed against the c-Myc tag of the proteins in combination with a suitable secondary alkaline-phosphatase-conjugated antibody (Sigma). Proteins were visualized using the chromogenic substrate solution NBT/BCIP (Roche Diagnostics).
Computer-aided analysis. Nucleotide and amino acid sequences were analysed using Vector NTI Suite (Informax) and NCBI BLAST search analysis (Altschul et al., 1997) . Amino acid sequence alignment was done using the Vector NTI Suite software and topology prediction was performed using HMMTOP (Tusnady & Simon, 1998) .
Complementation analysis of the L. pneumophila lepB gene.
The complementation assay protocol was similar to those described previously (Inada et al., 1989; Cregg et al., 1996; Chu et al., 2002) . E. coli strain IT89 (temperature-sensitive lepB mutant) was transformed with either pEXLepLpn, pBCNLepLpn or control plasmids pEX50 or pBCN. Single transformants were grown overnight in LB medium at 27 uC. After dilution to an OD 540 of 0?02, cultures were grown at the non-permissive temperature 42 uC in the absence of IPTG and the OD 540 was followed as a function of time.
In addition, growth of E. coli IT89(pEXLepLpn) at 42 uC was monitored in the presence of 1 mM or 2 mM IPTG to stimulate expression of the L. pneumophila lepB gene. 
RESULTS AND DISCUSSION
Cloning and sequence analysis of the L. pneumophila lepB gene
In order to determine whether L. pneumophila possesses one or more type I signal peptidase genes, a BLAST (tBlastn) search for genes encoding homologues of the E. coli leader peptidase (LepB) was carried out on the (as yet incomplete) L. pneumophila genome sequence (available at http:// genome3.cpmc.columbia.edu/~legion/). This screening revealed one, not yet annotated, ORF of 756 bp. This gene was cloned by PCR from L. pneumophila genomic DNA as described in Methods and the DNA sequence of the genome bank could be confirmed. Using Southern blot hybridization of L. pneumophila genomic DNA with a DIG-labelled lepB-specific probe, the presence of only one SPase gene could be demonstrated (Fig. 1) . The isolated L. pneumophila gene (GenBank/EMBL accession no. AJ608705) was predicted to code for a SPase protein (251 aa with a predicted molecular mass of 28?8 kDa) according to its overall homology with SPase proteins of other bacteria.
In Fig. 2(a) , an alignment of the deduced amino acid sequence of L. pneumophila LepB with SPase I proteins of other important Gram-negative human pathogens is shown. Overall sequence similarity with these SPases is 40-65 %. In particular, five regions of high conservation were identified; these regions, designated boxes A, B, C, D and E, are conserved in all type I SPases (Dalbey et al., 1997) and contain all the residues important for activity. The deduced amino acid sequence of L. pneumophila lepB is most similar to that of Pseudomonas aeruginosa. In both proteins, the region between boxes D and E is typically shorter compared to E. coli-like SPases.
Among the conserved domains, box A is a part of an amino-terminal transmembrane segment. Conserved box B contains the catalytic Ser (Ser90 in E. coli numbering) and is characterized by the consensus motif [IPSGSMxPTLx] . The consensus sequence is read with the bold upper-case character meaning absolutely conserved, the upper case character meaning conserved and 'x' meaning not conserved. In L. pneumophila LepB, the Met in this consensus motif is replaced by Leu. Note that in all naturally occurring SPase I enzymes described so far, this Met was strictly conserved. Site-directed mutagenesis of Bacillus subtilis SipS showed that the corresponding Met (Met44 in B. subtilis numbering) could be replaced by Ala without losing activity (van Dijl et al., 1995) , but until now, there has been no report on the natural occurrence of other residues than Met at this position. From the E. coli SPase structure, it was concluded that Met91 is part of the S1 substrate-binding pocket and its replacement by a larger Leu residue in L. pneumophila LepB can therefore influence the substrate specificity of the SPase. Box C has conserved amino acids [RGDIVVFxxP] . The second catalytic residue Lys or His (Lys145 in E. coli numbering) is situated in box D, which has the consensus motif [YIKRxxGxPGDxV] . Box E is the largest conserved domain with the following motif: [VPxGxYFxMGDNRDNSxDSR] . It is noteworthy that the L. pneumophila LepB protein is small compared to other SPases from Gram-negative pathogens (251 aa versus 324 aa for E. coli LepB). The topology of type I SPases from Gram-negative bacteria can vary significantly. The large catalytic periplasmic domain is anchored to the cytoplasmic membrane by 1-3 amino-terminal transmembrane segments. Furthermore, an additional anchor may be present at the carboxy-terminus of the enzyme. Hydrophobicity analysis of the L. pneumophila LepB amino acid sequence suggested two hydrophobic segments (aa 1-21 and aa 43-63) to act as transmembrane anchors. The predicted topology (Fig. 2b) is therefore similar to that of E. coli LepB.
Transcriptional analysis of the L. pneumophila lepB gene
In the first instance, the organization of the genes in the neighbourhood of the lepB gene was analysed (Fig. 3a) . The lepB gene is situated in the middle of two other putative genes that are transcribed in the same direction. Upstream of lepB, a gene encoding a homologue of GTP-binding LepA proteins was found, while downstream of lepB, a gene encoding a ribonuclease III (Rnc) homologue is present. The intergenic region between the lepA and lepB gene is 72 bp, while that between the SPase gene and the putative rnc gene is 390 bp. The predicted ORFs located further upstream and downstream are transcribed in the opposite direction and encode proteins with homology to lytic murein transglycolases and an ATP-binding protein of an ABC transporter, respectively.
To investigate whether L. pneumophila expresses the lepB gene and whether the three unidirectionally described genes constitute an operon, RT-PCR experiments on total RNA were carried out (Fig. 3b) . Total RNA was isolated either from L. pneumophila grown to exponential and stationary phase in liquid culture, or from L. pneumophila grown intracellularly in A. castellanii. RT-PCR with primers LspF and LspR, both binding to the lepB gene, clearly showed the presence of a 0?8 kb transcript in the case of L. pneumophila grown in liquid culture, as well as in L. pneumophila cells arising from infection of, and intracellular multiplication within, A. castellanii. Similar results were obtained with RNA isolated from exponential-or stationary-phase cultures (data not shown). RT-PCR on RNase-treated samples, included to detect traces of DNA in the samples, did not result in a band on agarose gel, indicating the absence of DNA and hence confirming a specific RNAdependent amplification. In addition, the presence of a In, the cytoplasmic side of the inner membrane; Out, the periplasmic side of the inner membrane; CM, the cytoplasmic or inner membrane.
transcript of 1?7 kb comprising the three genes could be demonstrated, indicating that the three genes are cotranscribed. The lower intensity of the 1?7 kb fragment compared to that of the smaller fragments could be an indication of a post-transcriptional cleavage of the longer message but might also be the consequence of a lower stability of the mRNA, or even of a less efficient PCR amplification. Based on these results and taking into account that the more upstream located gene is transcribed in the opposite direction, we assume the presence of a promoter upstream of the lepA gene. Based on database analysis, the lepA-lepBrnc cluster, with highly variable intergenic distances, can also be found in the genomes of other Gram-negative human pathogens, such as enteropathogenic E. coli, Vibrio cholerae, Yersinia pestis, Haemophilus influenzae, Shigella flexneri and Salmonella typhimurium genomes. For most of the pathogens, however, information on transcriptional organization is not available. In contrast to L. pneumophila, where lepB and rnc are part of the same operon (lepAlepB-rnc), for E. coli it was shown that the lepB gene is situated in an operon structure together with the upstream lepA gene (March & Inouye, 1985) and this lep operon is followed immediately by the rnc operon. Recently, it was shown that in the case of the obligate intracellular pathogen Rickettsia rickettsii, the lepB gene is cotranscribed with the secF gene (encoding a membrane protein involved in protein translocation across the inner membrane), the nuoF gene (encoding a putative NADH dehydrogenase I chain F), and the rnc gene in the secF-nuoF-lepB-rnc cluster (Rahman et al., 2003) . In Rhodobacter capsulatus, no lepA is present but the lepB gene forms an operon with the downstream genes, rnc and era (encoding a GTP-binding protein) (Rauhut et al., 1996) . From these examples it is clear that, although homologous genes are often present in the lep region, the transcriptional organization can vary considerably between different organisms. A tripartite operon structure consisting of lepA-lepB-rnc as observed in L. pneumophila is unique so far.
Expression and functional analysis of the L. pneumophila lepB gene in E. coli
Assessment of in vivo activity of L. pneumophila LepB depended on complementation of the temperaturesensitive LepB mutant of E. coli IT89 (Inada et al., 1989) . E. coli IT89 contains an amber mutation in the lepB gene at codon 39, which gives a temperature-sensitive phenotype (Cregg et al., 1996) . The strain shows normal growth at 27 uC, but growth is dramatically affected at the nonpermissive temperature (42 uC). This temperature-sensitive mutation can be complemented by a plasmid carrying a functional lepB gene. This assay has already been used to demonstrate type I SPase activity for SPase genes of Salmonella typhimurium (van Dijl et al., 1990) , Bradyrhizobium japonicum (Bairl & Müller, 1998; Müller et al., 1995) , Staphylococcus aureus (Cregg et al., 1996) , Streptococcus pneumoniae , Streptomyces lividans (Parro et al., 1999) , Bacillus amyloliquefaciens (Chu et al., 2002) , and Rickettsia rickettsii and Rickettsia typhi (Rahman et al., 2003) .
The L. pneumophila lepB gene was cloned on a low-copynumber (pEX50) and a high-copy-number (pBCN) plasmid to evaluate the effect of overexpression of L. pneumophila LepB on its complementation capacity. The pBCN plasmid has a 10 times higher copy number than pEX50. Growth of E. coli IT89 harbouring pEXLepLpn, pBCNLepLpn and the respective control plasmids pEX50 and pBCN at 42 u C was monitored in the absence of IPTG. Fig. 4 (a) clearly shows that L. pneumophila LepB supported growth at the non-permissive temperature, demonstrating that L. pneumophila LepB correctly inserts into the E. coli inner membrane and that it can process all E. coli proteins necessary for cell viability. The growth rate of E. coli IT89(pBCNLepLpn) was significantly retarded compared to that of E. coli IT89(pEXLepLpn). This observation, together with the finding that addition of 1 mM and 2 mM IPTG to E. coli IT89(pEXLepLpn) resulted in a decrease of growth rate, suggests that overexpression of the L. pneumophila lepB gene results in lethality.
Expression of L. pneumophila LepB in E. coli was analysed using Western blotting. A protein of approximately 28 kDa was detected in the E. coli IT89 strains harbouring pEXLepLpn or pBCNLepLpn, which was not present in the control (Fig. 4b) . The production of L. pneumophila LepB in E. coli IT89(pBCNLepLpn) was significantly higher compared to its production in E. coli IT89(pEXLepLpn); this most likely results from the difference in copy number of the expression vector. No significant increase in L. pneumophila LepB production was detected in E. coli IT89(pEXLepLpn) upon addition of IPTG as monitored by Western blotting (Fig. 4b) ; however, a negative effect on the growth rate was observed (Fig. 4a) . From this we conclude that the higher the production of L. pneumophila LepB was, the more the growth rate of the respective E. coli IT89 strain was retarded, which is in agreement with the hypothesis of overexpression lethality. Similar effects on the viability of E. coli were also observed when the SPases from B. amyloliquefaciens were overexpressed (Chu et al., 2002) .
Effect of a penem derivative on the activity of L. pneumophila LepB
To evaluate L. pneumophila LepB as a target for novel antibiotics, growth of E. coli IT89(pEXLepLpn) and L. pneumophila was monitored in the presence and absence of (5S,6S)-6-[(R)-acetoxyethyl]-penem-3-carboxylate, a specific SPase inhibitor (Allsop et al., 1995; Black & Bruton 1998; Paetzel et al., 1998) . As a control, the effect of adding DMSO, used to dissolve the penem compound, was included. Fig. 5 shows that addition of 100 mM (5S,6S)-6-[(R)-acetoxyethyl]-penem-3-carboxylate resulted in a clear reduction (14-18 %) of the growth of E. coli IT89(pEXLepLpn) cells at 42 u C compared to the control with only DMSO added. A clearly retarded growth (18-25 %) was also observed when L. pneumophila was grown in BYE medium containing 100 mM of the penem derivative. In this case, no effect due to the addition of DMSO was observed. For both strains, reduction of the growth was observed for exponentially-growing cells as well as for stationary-phase cultures. The antibacterial activity of the penem derivative is limited, most likely because of the difficulty in penetrating the outer membrane to reach its target (Black & Bruton, 1998) . When present in a similar concentration (100 mM), this compound was reported to cause a 31 % reduction of the growth of E. coli TOP10(pMB2) (Barbosa et al., 2002) .
This penem derivative has been already shown to inhibit SPase activity of E. coli LepB (Black & Bruton, 1998) , Staphylococcus aureus SpsB (Paetzel et al., 2000) , Streptomyces lividans SipW, SipX, SipY and SipZ (Geukens et al., 2002) , and the SPases from cyanobacterium and chloroplast thylakoids (Barbrook et al., 1996) . Recently, lipopeptides have been developed which are more effective in SPase inhibition (Paetzel et al., 2002; Bruton et al., 2003) . All these experiments demonstrate that SPase could be a valuable target for medicinal intervention. L. pneumophila (37 6C) in the absence (A) or presence (C) of the penem derivative. In the control, the same amount of DMSO as used to dissolve the penem compound, was added (B). Cultures were started from an initial OD 540 of 0?02 and 0?2 for E. coli and L. pneumophila, respectively, and samples were taken during exponential and stationary growth as described in Methods. Growth of bacterial strains in the presence of penem or DMSO was calculated as a percentage of the growth in the absence of both compounds (see Methods for absolute OD 540 values). Error bars indicate the standard deviation of at least two independent experiments.
